查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605886

芽球性浆细胞先生树突状细胞肿瘤市场，规模，占有率，趋势，产业分析报告:不同治疗，各终端用户，各地区 - 市场预测 2025年～2034年

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share, Trends, Industry Analysis Report: By Treatment, End Users, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，母细胞性浆细胞样树突状细胞瘤 (BPDCN) 的市场预计到 2034 年将达到 2,828.1 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于人们对该疾病的认识不断提高以及治疗方案的进步，母细胞性浆细胞样树突状细胞肿瘤 (BPDCN) 市场正在经历显着增长。主要驱动因素包括 BPDCN 盛行率的上升以及标靶疗法和创新疗法的开发，包括正在扩大治疗领域的新型药物和免疫疗法。

市场机会得到了正在进行的研究、临床试验以及旨在改善患者治疗结果的个人化医疗方法的引入的支持。日益重视早期诊断和下一代定序技术整合等趋势也预计将塑造市场。总体而言，由于这些因素着重于改善治疗选择和加强患者护理，BPDCN 市场预计将显着成长。

母细胞样浆细胞样树突细胞肿瘤市场报告重点

根据治疗分析，免疫疗法是成长最快的 BPDCN 市场。这是因为标靶治疗和检查点抑制剂的进步在 BPDCN 的治疗中显示出了有希望的结果。由于其有效性和副作用减少，免疫疗法比传统化疗越来越受欢迎。

在最终用户分析中，医院凭藉先进的基础设施和综合的治疗能力，在 BPDCN 治疗市场中占据主导地位。专科诊所也在不断增长，反映出更加重症监护并提供专业治疗和患者管理的趋势。

在先进的医疗基础设施和大量研究活动的支持下，北美仍然是 BPDCN 最大的市场。然而，由于医疗保健投资的增加和 BPDCN 意识的增强，亚太地区成为成长最快的地区。

积极参与 BPDCN 市场的主要公司包括Stemline Therapeutics公司(现在是Menarini Group旗下)，Celgene Corporation公司(Bristol-Myers Squibb公司收购)，Pfizer Inc.公司，Johnson &Johnson公司，Novartis AG公司，Takeda Pharmaceutical公司，Amgen Inc.公司，Gilead Sciences公司，F． Hoffmann-La Roche Ltd.公司，Merck &Co., Inc.公司，AbbVie Inc.公司，AstraZeneca公司，Sanofi公司，Bayer AG公司，Incyte 有Corporation公司等。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球芽球性浆细胞先生树突状细胞肿瘤市场洞察

  • 市场概述
  • 芽球性浆细胞先生树突状细胞肿瘤市场动态
    • 促进因素和机会
      • 越来越多地采用标靶治疗
      • 诊断技术的进步
    • 抑制因素和挑战
      • 治疗费用高昂
  • PESTEL分析
  • 芽球性浆细胞先生树突状细胞肿瘤市场终端用户趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球芽球性浆细胞先生树突状细胞肿瘤市场:不同治疗

  • 主要调查结果
  • 简介
  • 化疗
  • 免疫疗法
  • 干细胞移植

第6章 全球芽球性浆细胞先生树突状细胞肿瘤市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 专门诊所
  • 其他

第7章 全球芽球性浆细胞先生树突状细胞肿瘤市场:各地区

  • 主要调查结果
  • 简介
    • 芽球性浆细胞先生树突状细胞肿瘤市场评估:各地区，2020～2034年
  • 北美
    • 北美:不同治疗，2020～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:不同治疗，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:不同治疗，2020～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:不同治疗，2020～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:不同治疗，2020～2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • Stemline Therapeutics(Menarini Group)
  • ImmunoGen, Inc.
  • Mustang Bio
  • Genentech, Inc.
  • Jazz Pharmaceuticals, Inc.
  • Cellex Patient Treatment GmbH
  • Xencor
  • Resverlogix
  • Celgene Corporation(Bristol-Myers Squibb)
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
Product Code: PM5233

The blastic plasmacytoid dendritic cell neoplasm market size is expected to reach USD 282.81 billion by 2034, according to a new study by Polaris Market Research. The report "Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Immunotherapy, and Stem Cell Transplantation), End Users, Region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blastic plasmacytoid dendritic cell neoplasm market is experiencing significant growth driven by increasing awareness of the disease and advancements in treatment options. Key drivers include the rising incidence of BPDCN and the development of targeted therapies and innovative treatments, such as novel drugs and immunotherapies, which are expanding the treatment landscape.

Opportunities in the market are supported by ongoing research and clinical trials aimed at improving patient outcomes and the introduction of personalized medicine approaches. Trends such as the growing emphasis on early diagnosis and the integration of next-generation sequencing techniques are also expected to shape the market. Overall, the BPDCN market is expected to grow substantially due to these factors, with a focus on improving therapeutic options and enhancing patient care.

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Report Highlights

By treatment analysis, immunotherapy is the most rapidly growing segment in the BPDCN market. This is due to its promising outcomes in BPDCN treatment, driven by advancements in targeted therapies and checkpoint inhibitors. Immunotherapy is being increasingly preferred over traditional chemotherapy due to its efficacy and reduced side effects.

By end users analysis, the hospital segment dominates the market for BPDCN treatments, owing to their advanced infrastructure and comprehensive care capabilities. Specialty clinics are also seeing growth as they offer specialized treatments and patient management, reflecting a trend toward more focused care.

North America remains the largest market for BPDCN, supported by advanced healthcare infrastructure and high research activity. However, Asia Pacific is the fastest-growing region, driven by increasing investments in healthcare and rising awareness of BPDCN.

Major players actively participating in the BPDCN market include Stemline Therapeutics (now part of Menarini Group); Celgene Corporation (acquired by Bristol-Myers Squibb); Pfizer Inc., Johnson & Johnson; Novartis AG; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; AbbVie Inc.; AstraZeneca; Sanofi; Bayer AG; and Incyte Corporation.

Polaris market research has segmented the blastic plasmacytoid dendritic cell neoplasm market report based on treatment, end users, and region:

By Treatment Outlook (Revenue - USD Billion, 2020-2034)

  • Chemotherapy
  • Immunotherapy
  • Stem Cell Transplantation

By End Users Outlook (Revenue - USD Billion, 2020-2034)

  • Hospitals
  • Specialty Clinics
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of the Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Insights

  • 4.1. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Market Snapshot
  • 4.2. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Adoption of Targeted Therapies
      • 4.2.1.2. Advancements in Diagnostic Techniques
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • 5.3. Chemotherapy
    • 5.3.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
  • 5.4. Immunotherapy
    • 5.4.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
  • 5.5. Stem Cell Transplantation
    • 5.5.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Stem Cell Transplantation, by Region, 2020-2034 (USD Million)

6. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Hospitals, by Region, 2020-2034 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - North America
    • 7.3.1. North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
    • 7.3.2. North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.3.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - US
      • 7.3.3.1. US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.3.3.2. US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.3.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Canada
      • 7.3.4.1. Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • 7.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Europe
    • 7.4.1. Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
    • 7.4.2. Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - UK
      • 7.4.3.1. UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - France
      • 7.4.4.1. France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.4.2. France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Germany
      • 7.4.5.1. Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Italy
      • 7.4.6.1. Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Spain
      • 7.4.7.1. Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.8. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Netherlands
      • 7.4.8.1. Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.9. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Russia
      • 7.4.9.1. Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.4.10. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • 7.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Asia Pacific
    • 7.5.1. Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - China
      • 7.5.3.1. China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.3.2. China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - India
      • 7.5.4.1. India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.4.2. India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Malaysia
      • 7.5.5.1. Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Japan
      • 7.5.6.1. Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Indonesia
      • 7.5.7.1. Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.8. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - South Korea
      • 7.5.8.1. South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.9. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Australia
      • 7.5.9.1. Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.5.10. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • 7.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.6.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.6.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - UAE
      • 7.6.4.1. UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.6.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Israel
      • 7.6.5.1. Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.6.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - South Africa
      • 7.6.6.1. South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.6.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • 7.7. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Latin America
    • 7.7.1. Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.7.3. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Mexico
      • 7.7.3.1. Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.7.4. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Brazil
      • 7.7.4.1. Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.7.5. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Argentina
      • 7.7.5.1. Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
    • 7.7.6. Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Stemline Therapeutics (Menarini Group)
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ImmunoGen, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Mustang Bio
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Genentech, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Jazz Pharmaceuticals, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Cellex Patient Treatment GmbH
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Xencor
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Resverlogix
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Celgene Corporation (Bristol-Myers Squibb)
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Pfizer Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Johnson & Johnson
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Novartis AG
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development

List of Tables:

  • Table 1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 2 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 3 North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 4 North America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 5 US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 6 US: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 7 Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 8 Canada: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 9 Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 10 Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 11 UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 12 UK: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 13 France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 14 France: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 15 Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 16 Germany: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 18 Italy: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 19 Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 20 Spain: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 21 Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 22 Netherlands: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 23 Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 24 Russia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 29 China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 30 China: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 31 India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 32 India: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 34 Malaysia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 35 Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 36 Japan: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 38 Indonesia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 39 South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 40 South Korea: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 42 Australia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 49 UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 50 UAE: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 51 Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 52 Israel: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 53 South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 54 South Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 57 Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 58 Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 59 Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 60 Mexico: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 62 Brazil: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 63 Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 64 Argentina: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment
  • Figure 7. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment, 2024 & 2034 (USD Million)
  • Figure 8. Market by End Use
  • Figure 9. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use, 2024 & 2034 (USD Million)